About Gyre Therapeutics, Inc. 
Gyre Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 8 Schemes (2.16%)
Foreign Institutions
Held by 17 Foreign Institutions (0.24%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
27 Million
(Quarterly Results - Jun 2025)
Net Profit:
2 Million
Pharmaceuticals & Biotechnology
USD 717 Million (Micro Cap)
NA
0.00%
-0.58
-999,999.00%
7.79






